LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Fresenius Medical Care AG & Co. KGAA (“Fresenius” or the “Company”) (NYSE: FMS) concerning possible violations of federal securities laws.
If you are a shareholder who suffered a loss during the Class Period, we encourage you to click here or contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights free of charge. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at firstname.lastname@example.org.
Fresenius is a kidney dialysis company that offers dialysis treatment and similar dialysis care services, and other health services.
On January 7, 2017, Fresenius disclosed that it received subpoenas from federal prosecutors due to the Company’s interactions with the American Kidney Fund, a national charity providing financial aid for kidney dialysis patients.
When this information was released to the public, Fresenius stock fell as much as 6.70% on January 9, 2017, causing investors severe harm.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at email@example.com.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.